Effect of Adrenocorticotropin Stimulation on the Synthesis of 19-Noraldosterone in Man

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 5, 1996, Pages 1852-1855

  Takeda, Yoshiyu ^a   Miyamori, Isamu ^a   Yoneda, Takashi ^a   Furukawa, Kenji ^a   Hatakeyama, Haruhiko ^a   Inaba, Satoru ^a   Ito, Yuji ^a   Takeda, Ryoyu ^b   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KKR Hokuriku Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

18 HYDROXY 19 NORCORTICOSTERONE; 18 HYDROXYCORTICOSTERONE; ALDOSTERONE; ALDOSTERONE DERIVATIVE; ANGIOTENSIN; CORTICOSTERONE DERIVATIVE; CORTICOTROPIN; MINERALOCORTICOID;

ADULT; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DOSE RESPONSE; GLOMERULOSA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STEROIDOGENESIS; URINARY EXCRETION;

18-HYDROXYCORTICOSTERONE; ADRENOCORTICOTROPIC HORMONE; ADULT; ALDOSTERONE; ANGIOTENSIN II; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MIDDLE AGED; ZONA GLOMERULOSA;

EID: 0029940069     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.81.5.8626846     Document Type: Article

References (33)

1. Perrone RD, Schwartz JH, Bengele HH, Dale SL, Melby JC, Alexander EA. 1981 Mineralocorticoid activity of 19-nor-DOC and 19-OH-DOC in toad bladder. Am J Physiol. 4:E406-E409.
2. Gorsline J, Morris DJ. 1985 The hypertensinogenic activity of 19-nor-deoxycorticosterone in the adrenalectomized spontaneously hypertensive rats. J Steroid Biochem. 23:535-536.
3. Ulick S. 1976 Adrenocortical factors in hypertension. I. Significance of 18-hydroxy-11-deoxycorticosterone. Am J Cardiol. 38:814-824.
4. Biglieri EG, Irony I, Kater CE. 1989 Identification and implications of new types of mineralocorticoid hypertension. J Steroid Biochem. 32:199-204.
5. Griffing GT, Dale SL, Holbrook MM, Melby JC. 1982 19-Nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension. J Clin Endocrinol Metab. 56:218-221.
6. Harnik M, Kashman Y, Cojocaru M, Rosenthal T, Morris DJ. 1986 Synthesis of 19-noraldosterone, a potent mineralocorticoid. J Steroid Biochem. 24:1163-1169.
7. 5-aldosterone: relative potencies measured in two bioassay systems. Endocrinology. 118:2505-2509.
8. Morris DJ, Gorsline J, Tresco PA, Harnik M. 1985 The effects of 19-noraldosterone on blood pressure of adrenalectomized spontaneously hypertensive rats. Steroids. 46:1003-1010.
9. Godzsa J, Vecsei P, Iwuanyanwu T, Harnik M. 1989 18,19-Dihydroxycorticosterone: new metabolite in human urine. Endocr Rev. 15:151-157.
10. Takeda Y, Bige K, Iwuanyanwu T, et al. 1991 Urinary 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone excretion in patients with primary and secondary aldosteronism. Steroids. 56:566-570.
11. Rosenthal T, Shani M, Peleg E, Harnik M. 1988 The hypertensinogenic activity of 18-hydroxy-19-norcorticosterone in the adrenalectomized rat. Am J Hypertens. 1:49s-53s.
12. Framan S, Harnik M, Peleg E, Zamir N, Rosenthal T. 1992 The hypertensinogenic activity of 18,19-dihydroxycorticosterone in adrenalectomized rat. Am J Hypertens. 5:399-401.
13. Takeda Y, Miyamori I, Takeda R, Lewicka S, Vecsei P. 1992 Effect of sodium restriction on urinary excretion of 19-noraldosterone and 18,19-dihydroxycorticosterone, newly identified mineralocorticoids in man. J Clin Endocrinol Metab. 74:1195-1197.
14. Griffing GT, Dale SL, Holbrook MM, Melby JC. 1981 19-Nordeoxycorticosterone excretion in healthy and hypertensive subjects. Trans Assoc Am Physicians. 94:301-303.
15. Takeda Y, Miyamori I, Iki K, Takeda R, Vecsei P. 1992 Urinary excretion of 19-noraldosterone, 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism. Acta Endocrinol (Copenh). 126:484-488.
16. Takeda Y, Miyamori I, Karayalcin U, Takeda R. 1991 Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, pravastatin, on corticosteroid metabolism in patients with heterozygous familial hypercholesterolemia. Horm Res. 36:75-77.
17. Iki K, Miyamori I, Hatakeyama H, et al. 1994 The activities of 5β-reductase and 11β-hydroxysteroid dehydrogenase in essential hypertension. Steroids. 59:656-660.
18. Takeda R, Morimoto S, Uchida K, Miyamori I. 1976 Changes in plasma renin activity and plasma aldosterone in the induced paralytic attack of thyrotoxic periodic paralysis. Acta Endocrinol (Copenh). 82:715-727.
19. Takeda Y, Lewicka S, Koch S, et al. 1990 Synthesis of 19-noraldosterone, 18-hydroxy-19-norcorticosterone and 18,19-dihydroxycorticosterone in the human aldosterone-producing adenoma. J Steroid Biochem Mol Biol. 37:599-604.
20. Rácz K, Varga I, Gláz E, et al. 1982 Met-enkephalin inhibits mineralocorticoid production in isolated human aldosteronoma cells. J Clin Endocrinol Metab. 54:656-660.
21. Takeda Y, Miyamori I. 1994 19-Noraldosterone, a new mineralocorticoid. Endocr J. 41:483-489.
22. Imai M, Ogishima T, Shimada H, Ishimura Y. 1992 Effect of dietary sodium restriction on mRNA for aldosterone synthase cytochrome P-450 in rat adrenals. J Biochem. 111:440-443.
23. Takeda Y, Miyamori I, Iki K, Yoneda T, Takeda R. 1994 Biosynthetic pathway of 19-noraldosterone in isolated rat glomerulosa cells. J Steroid Biochem Mol Biol. 49:69-71.
24. Kem DC, Gomez-Sanchez CE, Kramer NJ, Holland OB, Higgins JR. 1975 Plasma aldosterone and renin activity response to ACTH infusion in dexamethasone-suppressed normal and sodium depleted man. J Clin Endocrinol Metab. 40:116-124.
25. Gomez-Sanchez CE, Clore JN, Estep HL, Watlington CO. 1988 Effect of chronic adrenocorticotropin stimulation on the excretion of 18-hydroxycortisol and 18-oxocortisol. J Clin Endocrinol Metab. 67:322-326.
26. Dubois RN, Simpson ER, Kramer RE, Waterman MR. 1981 Induction of synthesis of cholesterol side chain cleavage cytochrome P 450 by adrenocorticotropin cultured bovine adrenocortical cells. J Biol Chem. 256:7000-7005.
27. Kramer RE, Simpson ER, Waterman MR. 1983 Induction of 11β-hydroxylase by corticotropin in primary cultures of bovine adrenocortical cells. J Biol Chem. 258:3000-3006.
28. Funkenstein B, McCarthy JL, Dus KM, Simpson ER, Waterman MR. 1983 Effect of adrenocorticotropin on steroid 21-hydroxylase synthesis and activity in cultured bovine adrenocortical cells. J Biol Chem. 258:9398-9405.
29. Zuber MX, Simpson ER, Hall PF, Waterman MR. 1985 Effects of adrenocorticotropin on 17α -hydroxylase activity and cytochrome P-45017α synthesis in bovine adrenocortical cells. J Biol Chem. 260:1842-188.
30. Müller J, Oertle M. 1993 Separate induction of the two isozymes of cytochrome P-45011β in rat adrnal zona glomerulosa cells. J Steroid Biochem Mol Biol. 47:213-221.
31. Haning R, Tait SAS, Tait JF. 1970 In vitro effects of ACTH, angiotensins, serotonin and potassium on steroid output and conversion of corticosterone to aldosterone by isolated adrenal cells. Endocrinology. 87:1147-1167.
32. Rosolowsky LJ, Campbell WB. 1990 Endothelin enhances adrenocorticotropin-stimulated aldosterone release from cultured bovine adrenla cells. Endocrinology. 126:1860-1866.
33. Azar ST, Melby JC. 1992 19-Nor-deoxycorticosterone production from aldosterone-producing adenomas. Hypertension. 19:362-364.